Thelma M. Watson

982 total citations
9 papers, 754 citations indexed

About

Thelma M. Watson is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Thelma M. Watson has authored 9 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Thelma M. Watson's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Immunotherapy and Immune Responses (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Thelma M. Watson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Immunotherapy and Immune Responses (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Thelma M. Watson collaborates with scholars based in United States and United Kingdom. Thelma M. Watson's co-authors include Barry L. Gause, Robin Pennington, Elaine S. Jaffe, Larry W. Kwak, Carol B. Kobrin, Dan L. Longo, Floyd A. Benko, P L Duffey, Maurizio Bendandi and Craig W. Reynolds and has published in prestigious journals such as Nature Medicine, Blood and Clinical Cancer Research.

In The Last Decade

Thelma M. Watson

9 papers receiving 734 citations

Peers

Countries citing papers authored by Thelma M. Watson

Since Specialization

Citations

This map shows the geographic impact of Thelma M. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thelma M. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thelma M. Watson more than expected).

Fields of papers citing papers by Thelma M. Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thelma M. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thelma M. Watson. The network helps show where Thelma M. Watson may publish in the future.

Co-authorship network of co-authors of Thelma M. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Thelma M. Watson. A scholar is included among the top collaborators of Thelma M. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thelma M. Watson. Thelma M. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	BiovaxID™ Vaccine Therapy of Follicular Lymphoma in First Remission: Long-Term Follow-Up of a Phase II Trial and Status of a Controlled, Randomized Phase III Trial. 2005 ·Blood ·(unknown), Lee Stern, (unknown), Thelma M. Watson, (unknown)	12
2	Human Autologous Tumor-Specific T-Cell Responses Induced by Liposomal Delivery of a Lymphoma Antigen 2004 ·Clinical Cancer Research ·Sattva S. Neelapu, Sivasubramanian Baskar, Barry L. Gause, Carol B. Kobrin, Thelma M. Watson, (unknown), Robin Pennington, Linda Harvey, Elaine S. Jaffe, R J Robb, Mircea Popescu, Larry W. Kwak	63
3	Pretreatment with Rituximab Does Not Inhibit the Human Immune Response against the Immunogenic Protein LMB-1 2004 ·Clinical Cancer Research ·Raffit Hassan, (unknown), Thelma M. Watson, Lee H. Pai-Scherf, Ira Pastan	45
4	Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia. 2000 ·PubMed ·Banu Arun, Brendan D. Curti, Dan L. Longo, (unknown), W. Gregory Alvord, Barry L. Gause, Thelma M. Watson, William C. Kopp, John E. Janik	13
5	Complete molecular remissions induced by patient-specific vaccination plus granulocyte–monocyte colony-stimulating factor against lymphoma 1999 ·Nature Medicine ·Maurizio Bendandi, Christopher D. Gocke, Carol B. Kobrin, Floyd A. Benko, Lars Sternås, Robin Pennington, Thelma M. Watson, Craig W. Reynolds, Barry L. Gause, P L Duffey, Elaine S. Jaffe, Stephen P. Creekmore, Dan L. Longo, Larry W. Kwak	458
6	Hepatotoxicity in cancer patients receiving erb-38, a recombinant immunotoxin that targets the erbB2 receptor. 1999 ·PubMed ·Lee H. Pai-Scherf, (unknown), Deborah A. Pearson, Thelma M. Watson, (unknown), M C Willingham, Ira Pastan	89
7	Abrogation of the Hematological and Biological Activities of the Interleukin-3/Granulocyte-Macrophage Colony-Stimulating Factor Fusion Protein PIXY321 by Neutralizing Anti-PIXY321 Antibodies in Cancer Patients Receiving High-Dose Carboplatin 1999 ·Blood ·Langdon L. Miller, Edward L. Korn, (unknown), John E. Janik, Barry L. Gause, William C. Kopp, Jon Holmlund, Brendan D. Curti, Mario Sznol, John W. Smith, Walter J. Urba, (unknown), Thelma M. Watson, Dan L. Longo	19
8	Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a. 1991 ·Blood ·(unknown), DL Longo, W J Urba, (unknown), Thelma M. Watson, Joy M. Beveridge, (unknown), Mario Sznol, (unknown), (unknown)	36
9	A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer. 1984 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), Thelma M. Watson, A E Maluish, Oldham Rk	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact